Filtration Group announced the acquisition of OXYPHEN, an innovator in track-etched membranes. As part of the Filtration Group family, Oxyphen has strengthened its ability to partner with customers in life science, consumer and industrial markets with its customized membrane solutions.
“We are excited to have a great entrepreneur like Annette Heusser and the team at Oxyphen joining us on our common mission to make the world safer, healthier and more productive,” said Tim McCarty, CEO of Filtration Group.
Track-etched membrane solutions
Track-etched membrane is a high-precision manufactured film used in critical applications for life science, automotive, industrial and consumer markets. Oxyphen’s track-etched membrane solutions complement the already extensive porous product offering and manufacturing capability within Filtration Group’s POREX business.
“Filtration Group is an ideal home for Oxyphen because we share a mission-driven and entrepreneurial culture that is customer-focused,” said Oxyphen CEO, Annette Heusser. “This will enable us to solve our customers’ most critical problems.”
Headquartered in Wetzikon, Switzerland, Oxyphen has more than 60 employees across two facilities in Europe.
